ChronoScale Corporation Common Stock (NASDAQ:CHRN) Shares Gap Up - Should You Buy?

Key Points

• CHRN shares briefly gapped higher, opening at $15.16 versus a prior close of $14.38, but later traded at $14.28 on volume of 12,966 shares.
• Analyst views are mixed: two analysts rate the stock Buy, one Hold, and one Sell. The consensus rating is Hold, with an average price target of $21.00 and individual targets ranging from $25 to $32.
• The company reported a quarterly loss of $0.29 per share, a negative net margin of 135.66%, and negative return on equity of 66.16%; analysts expect a full-year loss of $0.49 per share.

ChronoScale Corporation Common Stock (NASDAQ:CHRN - Get Free Report)'s share price gapped up before the market opened on Monday. The stock had previously closed at $14.38, but opened at $15.16. ChronoScale Corporation Common Stock shares last traded at $14.28, with a volume of 12,966 shares traded.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. Compass Point started coverage on ChronoScale Corporation Common Stock in a research note on Friday, October 16th. They issued a "buy" rating and a $25.00 price objective for the company. Northland Securities began coverage on shares of ChronoScale Corporation Common Stock in a research report on Friday, September 18th. They set an "outperform" rating and a $32.00 price target for the company. Finally, Weiss Ratings downgraded shares of ChronoScale Corporation Common Stock from a "sell (d)" rating to a "sell (d-)" rating in a report on Friday, October 23rd. Two research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $21.00.

ChronoScale Corporation Common Stock Stock Performance

The company has a 50-day moving average of $18.62 and a 200 day moving average of $15.97. The firm has a market capitalization of $2.08 billion, a PE ratio of -3.30 and a beta of 0.98. The company has a quick ratio of 0.30, a current ratio of 0.30 and a debt-to-equity ratio of 0.02.

ChronoScale Corporation Common Stock (NASDAQ:CHRN - Get Free Report) last posted its quarterly earnings data on Wednesday, October 14th. The company reported ($0.29) earnings per share for the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 66.16% and a negative net margin of 135.66%. The company had revenue of $41.48 million during the quarter. Equities research analysts predict that ChronoScale Corporation Common Stock will post -0.49 EPS for the current year.

ChronoScale Corporation Common Stock Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.